GAMMA Investing’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.4M Buy
10,776
+360
+3% +$83.7K 0.08% 184
2026
Q2
$2.47M Sell
10,416
-375
-3% -$77.9K 0.09% 167
2026
Q1
$2.28M Buy
10,791
+628
+6% +$135K 0.11% 165
2025
Q4
$2.09M Buy
10,163
+1,212
+14% +$228K 0.1% 160
2025
Q3
$1.4M Buy
8,951
+328
+4% +$50.7K 0.08% 214
2025
Q2
$1.45M Buy
8,623
+1,619
+23% +$240K 0.09% 192
2025
Q1
$965K Buy
7,004
+1,549
+28% +$197K 0.07% 251
2024
Q4
$645K Buy
5,455
+1,898
+53% +$222K 0.06% 299
2024
Q3
$393K Buy
3,557
+902
+34% +$94.3K 0.04% 388
2024
Q2
$261K Buy
2,655
+799
+43% +$81.4K 0.04% 428
2024
Q1
$208K Buy
1,856
+623
+51% +$67.2K 0.04% 378
2023
Q4
$135K Buy
+1,233
New +$122K 0.04% 428

Other funds holding CAH

GAMMA Investing's CAH Position: Q3 2026 in Review

GAMMA Investing increased its Cardinal Health (CAH) stake by 3.5% in Q3 2026, buying an estimated $83.7K and bringing the position to 10,776 shares worth $2.4M. The position accounts for 0.08% of the portfolio, ranked #184.

GAMMA Investing first reported a position in CAH in Q4 2023 and has held it in 12 quarters since. The position peaked at $2.47M in Q2 2026. 52 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • GAMMA Investing held 10,776 shares of Cardinal Health worth $2.4M as of Q3 2026.
  • GAMMA Investing bought 360 Cardinal Health shares in Q3 2026, an estimated $83.7K.
  • Cardinal Health made up 0.08% of GAMMA Investing's portfolio in Q3 2026, its #184 holding.
  • GAMMA Investing first reported a position in Cardinal Health in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Cardinal Health position peaked at $2.47M in Q2 2026.
  • 52 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.